Blood biomarkers may identify risk of colon cancer recurrence
Ludwig researchers working in collaboration with colleagues in Australia and the US have shown that fragments of tumour DNA circulating in the blood can be used to gauge the risk of colorectal cancer recurrence and the efficacy of chemotherapy following surgery. The finding is an important step toward the development of a non-invasive and more […]
